SCL SCIENCE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,800 KRW | +2.80% |
|
+9.05% | -0.79% |
| Sales 2022 | 370M 269K 367K | Sales 2023 | 1.32B 961K 1.31M | Capitalization | 64.19B 46.67M 63.74M |
|---|---|---|---|---|---|
| Net income 2022 | -5.97B -4.34M -5.93M | Net income 2023 | -5.03B -3.65M -4.99M | EV / Sales 2022 | 150 x |
| Net Debt 2022 | 7.42B 5.4M 7.37M | Net cash position 2023 | 1.05B 767K 1.05M | EV / Sales 2023 | 47.8 x |
| P/E ratio 2022 |
-7.57
x | P/E ratio 2023 |
-11.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.15% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.80% | ||
| 1 week | +9.05% | ||
| Current month | +1.38% | ||
| 1 month | +0.57% | ||
| 3 months | +9.18% | ||
| 6 months | +17.33% | ||
| Current year | -0.79% |
1 week
8 070.00
9 000.00
1 month
7 720.0010 770.00
Current year
7 600.0010 770.00
1 year
6 660.0010 770.00
3 years
6 660.0020 900.00
5 years
5 200.0027 800.00
10 years
5 200.0027 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 8,800 | +2.80% | 7,059 |
| 24-04-25 | 8,560 | -2.06% | 16,621 |
| 24-04-24 | 8,740 | +3.92% | 22,086 |
| 24-04-23 | 8,410 | +2.56% | 6,792 |
| 24-04-22 | 8,200 | +1.61% | 7,195 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
SCL Science Inc, formerly InnoTherapy Inc, is a Korea-based company principally engaged in the research, development, manufacture, export and sale of medical hemostatic agents. The main developed products include medical hemostats and sealants with biomimetic technology. In addition, the Company is engaged in the bio-logistics business.
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -0.79% | 46.27M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- A246960 Stock
